DBI
Acyl-CoA-binding protein
Also known as: ACBD1, ACBP, ACBP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07108
- Gene
- DBI
- Ensembl
- ENSG00000155368
- Chromosome
- 2
- Canonical length
- 87 aa
- Protein class
- Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. The protein is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrenal steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
87 residues, UniProt reviewed canonical sequence.
>P07108|DBI
1 MSQAEFEKAA EEVRHLKTKP SDEEMLFIYG HYKQATVGDI NTERPGMLDF TGKAKWDAWN
61 ELKGTSKEDA MKAYINKVEE LKKKYGILocalizationUniProt · AlphaFold · HPA
Whether an antibody against DBI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 1,095 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,095 nTPM
- parathyroid gland: 970 nTPM
- breast: 808 nTPM
- esophagus: 765 nTPM
- epididymis: 762 nTPM
- amygdala: 744 nTPM
Single-cell type
- esophageal suprabasal cells: 4,735 nCPM
- esophageal apical cells: 4,467 nCPM
- hepatocytes: 2,459 nCPM
- esophageal basal cells: 1,821 nCPM
- suprabasal keratinocytes: 1,642 nCPM
- epididymal principal cells: 1,417 nCPM
Immune cell
- basophil: 1,297 nTPM
- eosinophil: 1,203 nTPM
- plasmacytoid DC: 873 nTPM
- total PBMC: 872 nTPM
- myeloid DC: 835 nTPM
- T-reg: 676 nTPM
Brain region
- white matter: 248 nTPM
- spinal cord: 238 nTPM
- medulla oblongata: 236 nTPM
- pons: 216 nTPM
- hypothalamus: 209 nTPM
- midbrain: 199 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fatty acid metabolic process
- phosphatidylcholine acyl-chain remodeling
- positive regulation of phospholipid transport
Molecular functions
- benzodiazepine receptor binding
- fatty-acyl-CoA binding
- identical protein binding
- long-chain fatty acyl-CoA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DBI as an antibody target. Whether an autoantibody or antibody against DBI could matter depends on whether native DBI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DBI is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DBI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...